Archiwum hase³
abioseston | abjunction | ablactate | camphor | cananga oil | candelila wax {E902} | candidate genes | canthaxanthin {E161g} | canthaxanthine {E161g} | capacity | capric acid | carageen | carageenan | caramel color {E150} | caraway oil | caraway seed oil | carbon atom | carbon black {E153} | carbon dioxide {E290} | carbonic acid gas {E290} | carbonic anhydride | carboxymethyl cellulose {E466} | dextronic acid {E574} | di(2 ethylhexyl) sodium sulfosuccinate | diacetin | Diagnosis and Staging | diammonium citrate | diammonium hydrogen phosphate | diammonium phosphate {E342} | dibasic ammonium citrate | dibasic ammonium phosphate {E342} | dibasic calcium phosphate {E341b} | dibasic calcium pyrophosphate | dibasic potassium phosphate {E340b} | dibasic sodium phosphate {E339b} | dibenzyl ether | dibutyl sebacate | dicalciumortophosphate {E341b} | diethyl succinate | different schedules of administration | digestibility | diglyceride {E471} | dihydroacarveol | dika butter | dika nuts | dilauryl thiodipropionate | dill oil | dill seed oil | dillseed oil | dimeric immunoglobulin | dimethyl polysiloxane | dimethyl sulfide | dimethylaminoazobenzene | dimethylpolysiloxane | dipeptidyl boronic acid | dipotassium ortophosphate {E340b} | direct cytolysis of target cells | discontinue | G.R.A.S. list {GRAS} | gallate {E310} {312} | gastroenteritis | gastrointestinal disorders | gastrointestinal events | gastrointestinal haemorrhage | gaultheria oil | gel agent | gel-forming substance | gel-inducing agent | gelatin {E441} | gelling agent | gelling ingredient | gene transcription | General Disorders and Administration Site Conditions | general non-specific developmental disorders | rabbit | rabbit husbandry | rabbit population | raccoon dog | racing performance of their progeny | radical | radioimmunological method | radiological skeletal survey | rainbow trout | raisin-seed oil | ramified | Random Sample Test method | randomised | range of products | rapid turnover key cell cycle mediators | rare | RBC transfusion | re-orientated | re-stocking | reaction | rearing rate | reatment should be withheld at the onset of any toxicites | recombinant tissue plasminogen activator | recommended clinical dose | recommended dosage | recommended dose | reconstituted solution | reconstituted solution must be discarded | reconstructed embryos | reconstruction and development of the population | recording scheme | recurrent aphtosis | Red and White breed | red blood cell transfusions {RCB} | red marrow | reduce | reduced efficacy | reduction in reduction in plasma cells | refractory relapse | refractory to the last therapy | regionalisation | Registered Trademark | regulation of cyclin kinase activity | F.D. & C blue No. 1 {E133} | Failed Back Surgery Syndrome {FBSS} | FD & C blue no. 2 {E132} | FD & C red No. 4 {E124} | FD and C BlueNo.1 {E133} | FD and C green 3 | FD and C green no. 3 | FD and C red no. 3 {E127} | febrile neutropenia | feerrous gluconate {E579} | figurative sense of verbal statement | firming agent | fixative | flavin | flavor enhancer | florid plaques | fluorocarbon 115 | foal | foetation | fold | follow-up period | food additive | food color | food color additive | food coloring | food colour | for single use only | forestomach | forgetfullness | formal drug interaction studies | formal drug-drug interaction studies | formamine {E239} | formic acid | fra (X) syndrome (?) | fragile X syndrome | fragility of bones | fragmented sleep | p-cresol | p-dimethylaminoazobenzene | p-isopropylbenzaldehyde | p-menth-1-en-3-one | p-phenetolcarbamide | p-phenetylurea | P.V.P {E1201} | Paediatric Use | pancreatin | papayotin | paprika | para-cresol | para-dimethyl-aminoazobenzene | paraffin | paraffin wax | parahallucinations | paraisopropylbenzaldehyde | parameter | paraprotein | parental crossbred | parental flock | partial response rate {PR} | pasture | pathergy reaction | patients benefiting from treatment | patients on oral antidiabetic agents | patients refractory to all of the available agents | patients should be monitored closely and appropriate precautions taken | patients were randomised to one of two dosage groups | patients with advanced malignancies | peak | peanut oil | pearl moss | pectin | pedigree breeding | pedigree data | pedigree farm | pegu catechu extract | penetration through the bloodbrain barrier | pentameric immunoglobulin (IgM) | reentry | relapsing-remitting | relationship between response and overall survival | relative predominance | REM sleep behaviour disorder {RBD} | diaries |
Poprzednia 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 Nastêpna
